Advocacy groups set to meet with Senate staff members

Share this article:
CME advocates will take a targeted set of talking points with them this fall to meetings with representatives on Capitol Hill.

The Coalition for Healthcare Communication plans to speak with aides to Sens. Max Baucus and Charles Grassley, the ranking Democrat and Republican on the Senate Finance Committee respectively, about a bill co-sponsored by Grassley.

The Physician Payments Sunshine Act, also sponsored by Herb Kohl (D-WI), would require drug and device firms to report gifts to doctors.

“This isn't a transparency bill; this is a gotcha bill,” said John Kamp, coalition executive director. That's because not reporting payments would equate to violations with penalties ranging from $10,000 to $100,000 per violation, he said.

Kamp said he is also concerned that some people “wrongly think” that a gift to a physician is attendance at a certified CME program or receiving a stipend for being a faculty member.

Meanwhile, the Alliance for CME (ACME) is scheduled to have a sit-down with Senate staff Oct. 16 to provide information about the alliance's role in educating CME professionals, said Sue Ann Capizzi, ACME president. The meeting was prompted by the committee's report, “Use of Educational Grants by Pharmaceutical Manufacturers.” In an open letter to members in June, Capizzi explained that a task force was assembled to study the report and determine how best to address issues raised.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?